Composite Hydrogel Modulates Intrinsic Immune-Cascade Neovascularization for Ocular Surface Reconstruction after Corneal Chemical Injury.
composite hydrogel
corneal alkali burn
neovascularization
neutrophil extracellular traps
Journal
Gels (Basel, Switzerland)
ISSN: 2310-2861
Titre abrégé: Gels
Pays: Switzerland
ID NLM: 101696925
Informations de publication
Date de publication:
22 Aug 2023
22 Aug 2023
Historique:
received:
22
07
2023
revised:
15
08
2023
accepted:
21
08
2023
medline:
27
9
2023
pubmed:
27
9
2023
entrez:
27
9
2023
Statut:
epublish
Résumé
Ocular alkali burns recruit neutrophils and triggers neutrophil extracellular trap (NET)-neovascularization cascade effects that limit ocular surface reconstruction and functional repair. However, effective inhibition of the release of neutrophil extracellular traps after a corneal chemical injury, coordination of intrinsic immunity with corneal repair, and exploration of more effective and non-invasive drug-delivery modes are still urgently needed. Using an in vitro coculture system, we found that an alkaline environment stimulates neutrophils to release NETs, which can be regulated by deoxyribonuclease I (DNase I). Inspired by this, we loaded DNase I, which effectively regulates NETs, onto chitosan nanoparticles and combined them with silk fibroin to construct a composite hydrogel that can sustainably regulate NETs. The hydrogel reduced neutrophil extracellular trap production by 50% and neovascularization by approximately 70% through sustained DNase I release after a corneal alkali burn. The complex hydrogel promotes ocular surface reconstruction by modulating the intrinsic immune-cascade neovascularization effect, providing a new research basis for the construction of nanobiomaterials that modulate pathological neovascularization.
Identifiants
pubmed: 37754358
pii: gels9090676
doi: 10.3390/gels9090676
pmc: PMC10528829
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : National Natural Science Foundation of China
ID : 82102589
Organisme : Suzhou Gusu Health Talent Program
ID : GSWS2021007
Organisme : Medical Health Science and Technology Innovation Program of Suzhou
ID : SKY2022119
Organisme : the Young Talent Development Plan of Changzhou Health Commission
ID : CZQM2020091, CZQM2022017
Organisme : Youth Project of Changzhou Health Commission
ID : QN202129
Organisme : Jiangsu Province Elderly Health Project
ID : LKM2022052
Organisme : Science and Technology planning project Foundation of ChangZhou
ID : CJ20220097, CE20225071
Références
J Fr Ophtalmol. 2013 Sep;36(7):627-39
pubmed: 23891320
Mater Sci Eng C Mater Biol Appl. 2018 May 1;86:151-172
pubmed: 29525090
Int J Biomater. 2013;2013:146320
pubmed: 24194759
Cochrane Database Syst Rev. 2022 Sep 1;9:CD009379
pubmed: 36047788
Curr Eye Res. 2019 May;44(5):505-513
pubmed: 30595046
Semin Ophthalmol. 2019;34(4):205-210
pubmed: 31188043
J Histochem Cytochem. 2006 Apr;54(4):385-95
pubmed: 16234507
J Mol Recognit. 1994 Jun;7(2):65-70
pubmed: 7826675
Front Immunol. 2021 Nov 24;12:785222
pubmed: 34899751
Front Immunol. 2019 Jan 08;9:3076
pubmed: 30671057
Macromol Biosci. 2021 Aug;21(8):e2100031
pubmed: 33969643
Biomaterials. 1995 Nov;16(16):1211-6
pubmed: 8589189
Autoimmun Rev. 2016 Jul;15(7):704-13
pubmed: 26970490
Drug Dev Ind Pharm. 2013 Nov;39(11):1599-617
pubmed: 23153114
Autoimmun Rev. 2017 Nov;16(11):1160-1173
pubmed: 28899799
ACS Nano. 2019 Oct 22;13(10):11686-11697
pubmed: 31490650
Int J Mol Med. 2016 Oct;38(4):1003-11
pubmed: 27499172
Biomaterials. 2017 Jan;112:1-9
pubmed: 27741498
J Mater Sci Mater Med. 2020 May 13;31(5):48
pubmed: 32405818
Semin Ophthalmol. 2011 Jul-Sep;26(4-5):235-45
pubmed: 21958169
J Hepatol. 2021 Dec;75(6):1271-1283
pubmed: 34363921
Proc Natl Acad Sci U S A. 1989 Feb;86(3):933-7
pubmed: 2915988
Nat Rev Immunol. 2018 Feb;18(2):134-147
pubmed: 28990587
Int Immunopharmacol. 2020 Nov;88:106902
pubmed: 32829090
Blood. 2021 Jul 8;138(1):91-103
pubmed: 33881503
Nat Med. 2017 Mar 7;23(3):279-287
pubmed: 28267716
Cornea. 1993 Sep;12(5):383-90
pubmed: 8306658
Front Immunol. 2020 Oct 15;11:551057
pubmed: 33178183
Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15880-5
pubmed: 20798043
Int J Mol Med. 2016 Jul;38(1):75-82
pubmed: 27221536
Nat Immunol. 2021 Sep;22(9):1107-1117
pubmed: 34385713
Front Immunol. 2020 Sep 16;11:1749
pubmed: 33042107